<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">02105</article-id><article-id pub-id-type="doi">10.7554/eLife.02105</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>Tyrosine phosphorylation of RNA Polymerase II CTD is associated with antisense promoter transcription and active enhancers in mammalian cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-9814"><name><surname>Descostes</surname><given-names>Nicolas</given-names></name><aff><institution>Centre d'Immunologie de Marseille Luminy, Université Aix-Marseille</institution>, <addr-line><named-content content-type="city">Marseille</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-9994"><name><surname>Heidemann</surname><given-names>Martin</given-names></name><aff><addr-line><named-content content-type="department">Department of Molecular Epigenetics</named-content></addr-line>, <institution>Helmholtz Center Munich, Center of Integrated Protein Science Munich (CIPSM)</institution>, <addr-line><named-content content-type="city">Munich</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-9995"><name><surname>Spinelli</surname><given-names>Lionel</given-names></name><aff><institution>Centre d'Immunologie de Marseille-Luminy, Université Aix-Marseille</institution>, <addr-line><named-content content-type="city">Marseilles</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-10007"><name><surname>Schüller</surname><given-names>Roland</given-names></name><aff><addr-line><named-content content-type="department">Department of Molecular Epigenetics</named-content></addr-line>, <institution>Helmholtz Center Munich, Center of Integrated Protein Science Munich (CIPSM)</institution>, <addr-line><named-content content-type="city">Munich</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-9997"><name><surname>Maqbool</surname><given-names>Muhammad A</given-names></name><aff><institution>Institut de Génétique Moléculaire de Montpellier (IGMM), CNRS-UMR</institution>, <addr-line><named-content content-type="city">Montpellier</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-9998"><name><surname>Fenouil</surname><given-names>Romain</given-names></name><aff><institution>Centre d'Immunologie de Marseille-Luminy, Université Aix-Marseille</institution>, <addr-line><named-content content-type="city">Marseilles</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-9999"><name><surname>Koch</surname><given-names>Frederic</given-names></name><aff><addr-line><named-content content-type="department">Department of Developmental Genetics</named-content></addr-line>, <institution>Max Planck Institute for Molecular Genetics</institution>, <addr-line><named-content content-type="city">Berlin</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-10000"><name><surname>Innocenti</surname><given-names>Charlène</given-names></name><aff><addr-line><named-content content-type="department">Department of Oncology</named-content></addr-line>, <institution>Institut de Génomique Fonctionnelle</institution>, <addr-line><named-content content-type="city">Montpellier</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-10001"><name><surname>Gut</surname><given-names>Marta</given-names></name><aff><institution>Centre Nacional D'Anàlisi Genòmica</institution>, <addr-line><named-content content-type="city">Barcelona</named-content></addr-line>, <country>Spain</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-10002"><name><surname>Gut</surname><given-names>Ivo</given-names></name><aff><institution>Centre Nacional D'Anàlisi Genòmica</institution>, <addr-line><named-content content-type="city">Barcelona</named-content></addr-line>, <country>Spain</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-10005"><name><surname>Eick</surname><given-names>Dirk</given-names></name><aff><addr-line><named-content content-type="department">Department of Molecular Epigenetics</named-content></addr-line>, <institution>Helmholtz Center Munich, Center of Integrated Protein Science Munich (CIPSM)</institution>, <addr-line><named-content content-type="city">Munich</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-12581"><name><surname>Andrau</surname><given-names>Jean-Christophe</given-names></name><aff><institution>Insitut de Génétique Moléculaire de Montpellier (IGMM), CNRS-UMR</institution>, <addr-line><named-content content-type="city">Montpellier</named-content></addr-line>, <country>France</country><email>jean-christophe.andrau@igmm.cnrs.fr</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1172"><name><surname>Reinberg</surname><given-names>Danny</given-names></name><role>Reviewing editor</role><aff><institution>HHMI / NYU School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>09</day><month>05</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e02105</elocation-id><supplementary-material><ext-link xlink:href="elife-02105-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>17</day><month>12</month><year>2013</year></date><date date-type="accepted"><day>08</day><month>05</month><year>2014</year></date></history><permissions><copyright-statement>Copyright © 2014, Descostes et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Descostes et al</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>In mammals, the carboxy-terminal domain (CTD) of RNA polymerase (Pol) II consists of 52 conserved heptapeptide repeats containing the consensus sequence Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7.  Post-translational modifications of the CTD coordinate the transcription cycle and various steps of mRNA maturation. Here we describe Tyr1 phosphorylation (Tyr1P) as a hallmark of promoter (5' associated) Pol II in mammalian cells, in contrast to what was described in yeast. Tyr1P is predominantly found in antisense orientation at promoters but is also specifically enriched at active enhancers. Mutation of Tyr1 to phenylalanine (Y1F) prevents the formation of the hyper-phosphorylated Pol IIO form, induces degradation of Pol II to the truncated Pol IIB form and results in a lethal phenotype. Our results suggest that Tyr1P has evolved specialized and essential functions in higher eukaryotes associated with antisense promoter and enhancer transcription, and Pol II stability.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></back></article>